Suchergebnisse - "Zou, Zhengyun"

PubPharm (81)

1

Intratumor injection of BCG Ag85A high-affinity peptides enhanced anti-tumor efficacy in PPD-positive melanoma

enthalten in: Cancer immunology, immunotherapy : CII | 2024

von Qin, L. | Zhang, G. | Wu, Y. | +2

2

Intratumor injection of BCG Ag85A high-affinity peptides enhanced anti-tumor efficacy in PPD-positive melanoma

enthalten in: Cancer immunology immunotherapy | 2024

von Qin, L. | Zhang, G. | Wu, Y. | +2

3

A phase II study of efficacy and safety of the MEK inhibitor tunlametinib in patients with advanced NRAS-mutant melanoma

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Wei, X. | Zou, Z. | Zhang, W. | +21

4

Trauma plays an important role in acral melanoma : A retrospective study of 303 patients

enthalten in: Cancer medicine | 2024

von Huang, R. | Zhao, M. | Zhang, G. | +8

5

Trauma plays an important role in acral melanoma : A retrospective study of 303 patients

enthalten in: Cancer Medicine | 2024

von Huang, R. | Zhao, M. | Zhang, G. | +8

6

Membrane fusion nano-liposome capable of regulating tumor immune microenvironment in targeted manner and preparation method of membrane fusion nano-liposome

enthalten in: Europäisches Patentamt | 2023

von ZOU ZHENGYUN | YANG YUELING

7

Membrane fusion nano-liposome capable of regulating tumor immune microenvironment in targeted manner and preparation method of membrane fusion nano-liposome

enthalten in: Europäisches Patentamt | 2023

von ZOU ZHENGYUN | YANG YUELING

8

Safety and efficacy of Pucotenlimab (HX008) - a Humanized Immunoglobulin G4 Monoclonal Antibody in patients with locally advanced or metastatic melanoma: a single-arm, multicenter, phase II study

enthalten in: ResearchSquare.com | 2023

von Cui, C. | Chen, Y. | Luo, Z. | +17

9

Role of vascular endothelial growth factor in radiotherapy resistance to esophageal squamous cell carcinoma

enthalten in: Journal of cancer research and clinical oncology | 2023

von Li, X. | Su, X. | Yan, C. | +7

10

Safety and efficacy of Pucotenlimab (HX008) - a humanized immunoglobulin G4 monoclonal antibody in patients with locally advanced or metastatic melanoma : a single-arm, multicenter, phase II study

enthalten in: BMC cancer | 2023

von Cui, C. | Chen, Y. | Luo, Z. | +17

1
2
3
4
5
6
7
8
9
Nächster »
[9]